RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Development of Wound Management Products for the US: An Anomaly for Global Product Development Mode

Development of Wound Management Products for the US: An Anomaly for Global Product Development Model

Posted 01 December 2011 | By Mukesh Kumar

Wound care products are primarily aimed at ensuring timely wound healing and effective infection control. There are hundreds of wound care products available on the market, from over-the-counter (OTC) to prescription products. Most wound care products are topical and are approved as medical devices; but a few drugs and biologics have been approved for the treatment of wounds as well.

 

© 2022 Regulatory Affairs Professionals Society.